Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1303 studies found for:    "Stomach carcinoma"
Show Display Options
Rank Status Study
1 Completed Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
Condition: Gastric Cancer
Interventions: Drug: TS-1 (S-1);   Procedure: Surgery
2 Unknown  Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway
Condition: Stomach Neoplasms
Interventions: Drug: Triple therapy for H. pylori infection;   Drug: Cox-2 inhibitor
3 Unknown  Trial of S-1 Plus Cisplatin in Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: s-1 plus cisplatin;   Drug: 5-Fu plus cisplatin
4 Completed Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: TS-1 and cisplatin;   Drug: TS-1
5 Completed
Has Results
A Safety and Efficacy Study in Patients With Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: S-1/Cisplatin;   Drug: 5-FU/cisplatin
6 Completed Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: S-1;   Drug: S-1 plus CDDP;   Drug: 5-FU plus CDDP
7 Recruiting Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer
Condition: Stomach Neoplasms
Intervention: Biological: EPCAM-targeted CAR-T cells
8 Completed Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer
Condition: Gastric Cancer
Interventions: Drug: capecitabine;   Drug: cisplatin;   Drug: imatinib mesylate
9 Recruiting Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study
Condition: Gastric Cancer
Interventions: Drug: docetaxel,0xaliplatin,capecitabine;   Drug: oxaliplatin,capecitabine
10 Active, not recruiting Randomized Controlled Trials Comparing Clinical Outcomes of 3D Versus 2D Laparoscopic Surgery for Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Procedure: 3D Laparoscopic Surgery;   Procedure: 2D Laparoscopic Surgery
11 Recruiting Early Onset and Familial Gastric Cancer Registry
Condition: Gastric Cancer
Intervention: Behavioral: questionnaires
12 Completed Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
Condition: Gastric Cancer
Interventions: Drug: Taxotere-Cisplatin-5FU;   Drug: Immediate surgery
13 Recruiting Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients ("EXO-PPP Study")
Condition: Gastric Cancer
14 Unknown  Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients
Condition: Gastric Cancer
Interventions: Drug: Simvastatin;   Drug: Placebo
15 Unknown  An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: Taxotere, Fluorouracil, Leucovorin
16 Completed High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer
Condition: Gastric Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: leucovorin calcium
17 Completed S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric Carcinoma
Condition: Stomach Neoplasms
Intervention: Drug: S-1; Oxaliplatin; 5-Fu; Leucovorin Calcium
18 Terminated Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma
Condition: Gastric Cancer
Interventions: Drug: Tegafur/gimeracil/oteracil potassium (S-1), Krestin (PSK);   Drug: Tegafur/gimeracil/oteracil potassium (S-1)
19 Unknown  Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03)
Condition: Gastric Cancer
Intervention: Procedure: LATG
20 Recruiting Irinotecan as 3rd Line Therapy in Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: Irinotecan

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.